Austedo Adherence Rates Higher Than Xenazine’s, US Study Finds

Austedo Adherence Rates Higher Than Xenazine’s, US Study Finds

315955

Austedo Adherence Rates Higher Than Xenazine’s, US Study Finds

People with Huntington’s disease are more likely to take Austedo (deutetrabenazine) as directed, compared with the similar medication Xenazine (tetrabenazine), according to a new study. The study also found lower discontinuation rates with Austedo, which may suggest that, between these two treatments for chorea, Austedo tends to be better tolerated. “Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis,” was published in Neurology and Therapy. It was sponsored by Teva Pharmaceuticals,…

You must be logged in to read/download the full post.